<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11859949</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1542</article-id><article-id pub-id-type="other">EPV0952</article-id><article-id pub-id-type="pii">S0924933824015426</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Schizophreniform disorder. Clinical manifestations and diagnosis. Purposely a case</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Ba&#x000f1;&#x000f3;n Gonz&#x000e1;lez</surname><given-names>S. M.</given-names></name><xref rid="aff3371" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1391" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ogando Portilla</surname><given-names>N.</given-names></name><xref rid="aff3371" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gamo Bravo</surname><given-names>B.</given-names></name><xref rid="aff3371" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gonz&#x000e1;lez Laynez</surname><given-names>M. E.</given-names></name><xref rid="aff3372" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sekade Guti&#x000e9;rrez</surname><given-names>N.</given-names></name><xref rid="aff3371" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Garc&#x000ed;a S&#x000e1;nchez</surname><given-names>F.</given-names></name><xref rid="aff3373" ref-type="aff">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="aff3371"><sup>1</sup><institution>Hospital Universitario Infanta Sof&#x000ed;a</institution>, <city>Madrid</city></aff><aff id="aff3372"><sup>2</sup><institution>Hospital Universitario de Toledo</institution>, <city>Toledo</city></aff><aff id="aff3373"><sup>3</sup><institution>Hospital Universitario de M&#x000f3;stoles</institution>, <city>Madrid</city>, <country>Spain</country></aff><author-notes><corresp id="cor1391"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1517">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S742</fpage><lpage>S742</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824015426a.pdf"/><abstract><sec id="sec8362"><title>Introduction</title><p>Schizophreniform Disorder is described pretty similar to schizophrenia, but with the difference&#x000a0;of the symptoms duration which have to last for at least 1 month but less than 6 months. Patients have to be back at their baseline functional level once the disorder has resolved. This is a heterogeneous group of patients who have&#x000a0;either a disorder similar to schizophrenia or&#x000a0;something closer to a mood disorder.</p></sec><sec id="sec8363"><title>Objectives</title><p>
To analyze clinical, psychopathological and epidemiological characteristics of schizophreniform disorder and also review causes, incidence, prevalence, diagnostic, therapeutic tools&#x000a0;and the importance of maintaining the treatment, because of the abandonment of the treatment, which is a predictor of relapses.</p></sec><sec id="sec8364"><title>Methods</title><p>A review of the main impact literature&#x000a0;concerning schizophreniform disorder is done during the last five years: prevalence, incidence, pathogenesis and its relationship with other psychiatric disorders encoded in DSM-V are studied.</p></sec><sec id="sec8365"><title>Results</title><p>The etiology is unknown. Psychotic symptoms can be treated with antipsychotics for 3 to 6 months. They usually respond faster than patients with schizophrenia (75% vs 20% respond within 8 days).</p></sec><sec id="sec8366"><title>Conclusions</title><p>The disease has a favorable prognosis, and has similarities with mood disorders. However, some data suggest a close relationship to schizophrenia. In support of the relationship with mood disorders, patients have more affective symptoms and a better outcome than patients with schizophrenia.</p></sec><sec id="sec8367"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>